• 17 Hits
  • Search Condition : Filter (MeSH = CD8-Positive T-Lymphocytes / drug effects)
Species Resource Title
Human and Animal Cells RAW 264(RCB0535) Sustained inhibition of CSF1R signaling augments antitumor immunity through inhibiting tumor-associated macrophages.
Human and Animal Cells ATN-1(RCB1440) Antitumor immunostimulatory effect via cell-killing action of a novel extracorporeal blood circulating photodynamic therapy system using 5-aminolevulinic acid.
Human and Animal Cells , DNA material ACC-MESO-1(RCB2292) , ACC-MESO-4(RCB2293) , HMMME(RCB0819) , Human HLA-A*24:02:01 cDNA (RDB02871) Enhancing the immunogenicity of Wilms tumor 1 epitope in mesothelioma cells with immunoproteasome inhibitors.
Human and Animal Cells HSC-2(RCB1945) , HSC-3(RCB1975) , HSC-4(RCB1902) , Ca9-22(RCB1976) PAK4 inhibition augments anti-tumour effect by immunomodulation in oral squamous cell carcinoma.
Human and Animal Cells OP9(RCB1124) , OP9/G-DLL1(RCB2925) In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models.
Human and Animal Cells JLS-V9(RCB2651) Stromal reaction inhibitor and immune-checkpoint inhibitor combination therapy attenuates excluded-type colorectal cancer in a mouse model.
Human and Animal Cells PC-9(RCB4455) , RERF-LC-AI(RCB0444) 11β hydroxysteroid dehydrogenase 1: a new marker for predicting response to immune-checkpoint blockade therapy in non-small-cell lung carcinoma.
Human and Animal Cells LM8(RCB1450) Intravenous administration of the selective toll-like receptor 7 agonist DSR-29133 leads to anti-tumor efficacy in murine solid tumor models which can be potentiated by combination with fractionated radiotherapy.
Human and Animal Cells SLVL(RCB1702) Combination lenalidomide-rituximab immunotherapy activates anti-tumour immunity and induces tumour cell death by complementary mechanisms of action in follicular lymphoma.
DNA material pCAG-HIVgp (RDB04394) , pCMV-VSV-G-RSV-Rev (RDB04393) Role of leukotriene B4 12-hydroxydehydrogenase in α-galactosylceramide-pulsed dendritic cell therapy for non-small cell lung cancer.
Human and Animal Cells RAW 264(RCB0535) , L929(RCB1451) Double-stranded phosphodiester cytosine-guanine oligodeoxynucleotide complexed with calcium phosphate as a potent vaccine adjuvant for activating cellular and Th1-type humoral immunities.
Human and Animal Cells MKN45(RCB1001) The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor β1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-β1 and Suppresses Tumor Metastasis.
Human and Animal Cells LLC(RCB0558) Comprehensive Mechanism Analysis of Mesoporous-Silica-Nanoparticle-Induced Cancer Immunotherapy.
Human and Animal Cells LLC(RCB055) Antitumor and antimetastatic actions of eicosapentaenoic acid ethylester and its by-products formed during accelerated stability testing.
Human and Animal Cells OV2944-HM-1(RCB1483) IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer.
Mice RBRC00915 Type I interferons regulate eomesodermin expression and the development of unconventional memory CD8(+) T cells.
Mice RBRC01390 Control of disease tolerance to malaria by nitric oxide and carbon monoxide.